 |
 
|
|
|
|
Sunday, September 26, 2010
|
07.50
|
BREAKFAST BUFFET AT THE KLOSTERWIRT |
|
08.45
|
Introductory
Remarks: goals of the conference |
|
|
David BRENNER, San Diego, USA |
I. Basic Concepts
|
09.00
|
L-2 Development, repair and fibrosis: What is common and why it matters |
|
|
David WARBURTON, Los Angeles, USA - confirmed |
|
09.40
|
L-3 Role of host genetics in fibrosis |
|
|
Georgina L.HOLD, Aberdeen, United Kingdom - confirmed |
|
10.50
|
L-4 Infectious disease, the innate immune response and fibrosis |
|
|
Cory M.HOGABOAM, Ann Arbor, USA - confirmed |
|
11.30
|
L-5 Redox mechanisms in hepatic chronic wound healing and fibrogenesis |
|
|
Mauricio PAROLA, Torino, ITALY - confirmed |
II. Cells and Molecules Involved in Fibrosis Generation
|
12.10
|
L-6 The Myofibroblast: one function, multiple origins |
|
|
Alexis DESMOULIERE, Limoges, France - confirmed
|
|
14.00
|
L-7 The role of circulating mesenchymal cells (fibrocytes) in promoting fibrosis |
|
|
Richard BUCALA, New Haven, USA - confirmed |
|
14.40
|
L-8 Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic Disorders.
|
|
|
Sergio A.JIMENEZ, Philadelphia, PA, USA - confirmed
|
|
16.00
|
L-9 Connective Tissue Growth factor |
|
|
Janet Lynn CUNNINGHAM, Uppsala, Sweden - confirmed |
|
16.40
|
L-10 Bone morphogenetic Protein-7 |
|
|
Roel GOLDSCHMELING, Utrecht, The Netherlands - confirmed |
|
17.20
|
L-11 Matrix metalloproteinases in fibrotic lung remodeling. |
|
|
ANNIE PARDO, Universidad Nacional Autonoma de Mexico, Mexico - confirmed |
|
20.00
|
DINNER at the
Klosterwirt |
|
